2021
Donor specific anti-HLA antibodies and cardiac allograft vasculopathy: A prospective study using highly automated 3-D optical coherence tomography analysis
PAZDERNIK, Michal; Helena BEDANOVA; Zhi CHEN; Josef KAUTZNER; Vojtech MELENOVSKY et al.Základní údaje
Originální název
Donor specific anti-HLA antibodies and cardiac allograft vasculopathy: A prospective study using highly automated 3-D optical coherence tomography analysis
Autoři
PAZDERNIK, Michal; Helena BEDANOVA; Zhi CHEN; Josef KAUTZNER; Vojtech MELENOVSKY; Ivan MALEK; Antonij SLAVCEV; Michaela BARTONOVA; Vladimir KARMAZIN; Tomas ECKHARDT; Ales TOMASEK; Eva OZÁBALOVÁ; Tomas KOVARNIK; Peter WOHLFAHRT a Milan SONKA
Vydání
Transplant Immunology, Amsterdam, ELSEVIER, 2021, 0966-3274
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30213 Transplantation
Stát vydavatele
Nizozemské království
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 2.032
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14110/21:00122148
Organizační jednotka
Lékařská fakulta
UT WoS
EID Scopus
Klíčová slova anglicky
Cardiac allograft vasculopathy; Donor specific antibodies; Heart transplant; Intimal thickness
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 24. 8. 2021 08:58, Mgr. Tereza Miškechová
Anotace
V originále
Introduction: Recent studies suggested potential positive correlations between HLA-specific antibodies and development of cardiac allograft vasculopathy (CAV). Methods: This prospective two-center study investigated early progression of CAV by coronary optical coherence tomography in 1 month and 12 months after heart transplantation (HTx) in 104 patients. Detection and characterization of donor specific (DSA) and MHC class-I polypeptide-related sequence A (MICA) antibodies were performed before, 1, 6 and 12 months after transplantation. Results: During the first post-HTx year, we observed a significant reduction in the mean coronary luminal area (P < .001), and progression in mean intimal thickness (IT) (P < .001). DSA and anti-MICA occurred in 17% of all patients, but no significant relationship was observed between presence of DSA/anti-MICA and IT progression within 12 months after HTx. In contrast, we observed significant association between presence of DSA (p=0.031), de-novo DSA (p=0.031), HLA Class II DSA (p=0.017) and media thickness (MT) progression. Conclusion: Results of our study did not identify a direct association between presence of DSA/anti-MICA and intimal thickness progression in an early period after HTx. However, we found significant relationships between DSA and media thickness progression that may identify a newly recognized immune-pathological aspect of CAV.